Side-by-side comparison of AI visibility scores, market position, and capabilities
Bootstrapped creator support platform taking 0% of donations; 1M+ creators earned $150M+ total with Ko-fi Gold subscription model competing with Patreon as fee-free alternative.
Ko-fi is a bootstrapped creator support platform that lets fans make one-time or recurring donations and purchases directly to creators — operating as a creator-friendly alternative to Patreon with a key differentiation: 100% of donations go directly to the creator (Ko-fi charges zero platform fees on donations), with revenue generated from Ko-fi Gold premium subscriptions ($6/month) and optional shop features. Founded in 2017 by Nigel Pickles and Simon Ellington, Ko-fi reached 1 million+ creators generating $150 million+ in total creator earnings with $3.8 million in annual platform revenue, operated by a 13-person team with no venture capital funding.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.